Dec. 31, 2012 ? As if space travel was not already filled with enough dangers, a new study out today in the journal PLOS ONE shows that cosmic radiation -- which would bombard astronauts on deep space missions to places like Mars -- could accelerate the onset of Alzheimer's disease.
"Galactic cosmic radiation poses a significant threat to future astronauts," said M. Kerry O'Banion, M.D., Ph.D., a professor in the University of Rochester Medical Center (URMC) Department of Neurobiology and Anatomy and the senior author of the study. "The possibility that radiation exposure in space may give rise to health problems such as cancer has long been recognized. However, this study shows for the first time that exposure to radiation levels equivalent to a mission to Mars could produce cognitive problems and speed up changes in the brain that are associated with Alzheimer's disease."
While space is full of radiation, the earth's magnetic field generally protects the planet and people in low earth orbit from these particles. However, once astronauts leave orbit, they are exposed to constant shower of various radioactive particles. With appropriate warning, astronauts can be shielded from dangerous radiation associated with solar flares. But there are also other forms of cosmic radiation that, for all intents and purposes, cannot be effectively blocked.
Because this radiation exists in low levels, the longer an astronaut is in deep space, the greater the exposure. This is a concern for NASA as the agency is planning manned missions to a distant asteroid in 2021 and to Mars in 2035. The round trip to the red planet, in particular, could take as long as three years.
For over 25 years, NASA has been funding research to determine the potential health risks of space travel in an effort to both develop countermeasures and determine whether or not the risks warranted sending men and women on extended missions in deep space.
Since that time, several studies have demonstrated the potential cancer, cardiovascular, and musculoskeletal impact of galactic cosmic radiation. The study out today for the first time examines the potential impact of space radiation on neurodegeneration, in particular, the biological processes in the brain that contribute to the development of Alzheimer's disease. O'Banion -- whose research focuses on how radiation affects the central nervous system -- and his team have been working with NASA for over eight years.
The researchers studied the impact of a particular form of radiation called high-mass, high-charged (HZE) particles. These particles -- which are propelled through space at very high speeds by the force of exploding stars -- come in many different forms. For this study the researcher chose iron particles. Unlikely hydrogen protons, which are produced by solar flares, the mass of HZE particles like iron, combined with their speed, enable them to penetrate solid objects such as the wall and protective shielding of a spacecraft.
"Because iron particles pack a bigger wallop it is extremely difficult from an engineering perspective to effectively shield against them," said O'Banion. "One would have to essentially wrap a spacecraft in a six-foot block of lead or concrete."
A portion of the research was conducted at the NASA Space Radiation Laboratory at Brookhaven National Laboratory on Long Island. NASA located its research operation at Brookhaven to take advantage of the Lab's particle accelerators which -- by colliding matter together at very high speeds -- can reproduce the radioactive particles found in space.
The researchers specifically wanted to examine whether or not radiation exposure had the potential to accelerate the biological and cognitive indicators of Alzheimer's disease, particularly in individuals who may be predisposed to developing the disease. To accomplish this they chose study the impact on animal models of Alzheimer's disease. These particular models have been extensively studied and scientists understand the precise timeframe in which the disease progresses over time.
At Brookhaven, the animals were exposed to various doses of radiation, including levels comparable to what astronauts would be experience during a mission to Mars. Back in Rochester, a team of researchers -- including URMC graduate student Jonathan Cherry, who was first author on the paper -- evaluated the cognitive and biological impact of the exposure. The mice underwent a series of experiments during which they had to recall objects or specific locations. The researchers observed that mice exposed to radiation were far more likely to fail these tasks -- suggesting neurological impairment -- earlier than these symptoms would typically appear.
The brains of the mice also showed signs of vascular alterations and a greater than normal accumulation of beta amyloid, the protein "plaque" that accumulates in the brain and is one of the hallmarks of the disease.
"These findings clearly suggest that exposure to radiation in space has the potential to accelerate the development of Alzheimer's disease," said O'Banion. "This is yet another factor that NASA, which is clearly concerned about the health risks to its astronauts, will need to take into account as it plans future missions."
Additional co-authors include Jacqueline Williams, Ph.D. and John Olschowka, Ph.D. with URMC and Bin Liu, Ph.D., Jeffrey Frost, and Cynthia Lemere, Ph.D. with Harvard Medical School. The study was funded by NASA.
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of Rochester Medical Center.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Jonathan D. Cherry, Bin Liu, Jeffrey L. Frost, Cynthia A. Lemere, Jacqueline P. Williams, John A. Olschowka, M. Kerry O?Banion. Galactic Cosmic Radiation Leads to Cognitive Impairment and Increased A? Plaque Accumulation in a Mouse Model of Alzheimer?s Disease. PLoS ONE, 2012; 7 (12): e53275 DOI: 10.1371/journal.pone.0053275
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/most_popular/~3/KBZnKWpQ1Gk/121231180632.htm
chipper jones chipper jones dancing with the stars cast mickael pietrus heart transplant the international preppers
A number of startups have attempted to create what might be termed the "Instagram for video". Now, before you throw up in your mouth at such an idea, consider the players so far. Well known Smule entered the race with its Strum app. Viddy, the popular social video app, shot for this target. And let's not forget Magisto, Lumify - and even good old iMovie. But there's no reason to assume anyone has cracked it, and now there's a new kid on the block in the form of FrameBlast on iOS [iTunes link].
Earlier today the sharing economy startup world was abruptly awoken from its holiday slumber with the news that car rental giant Avis would buy car-sharing company Zipcar for $500 million. No sooner had the news gotten out, though, that some shareholders in Zipcar have cried foul. The securities litigation firm of Powers Taylor, along with Willie Briscoe, the ex-U.S. SEC attorney, today announced that they would be investigating and possibly filing a lawsuit to block the deal. The premise: a $500 million acquisition price works out to shareholders getting $12.25 in cash for each share, below Zipcar’s 52-week high of $16.25 per share. “Due to the proposed sale price, the size of the deal and other factors, we believe this transaction may undervalue Zipcar?s stock,” said Briscoe in a statement. “Our proposed lawsuit will seek to obtain the highest share price for all shareholders.” Although Zipcar may have been trading at over $16 per share at some point in the last year, it’s not clear that this will be enough to block the deal. As we pointed out earlier today in a post when Avis’s Zipcar offer was announced, Zipcar has actually had a pretty bad time since going public in April 2011. It’s lost nearly two-thirds of its post-IPO value, when it was trading as high as $27.96. Its closing price on December 31 was significantly lower, with the $500 million offer from Avis representing a 49% premium on Zipcar’s trading price that day, of $8.24. On the other hand, Zipcar currently has 760,000 members across the U.S., UK and Canada. The lawyers cite at least one analyst that claims that the “true inherent value” of the company is at least $13 per share. The stock is currently trading at about $12.20 a share. So it will be a matter for the lawyers to convince shareholders that Zipcar has enough potential, and was undervalued significantly, to merit the case. The lawyers are now appealing to Zipcar shareholders to contact them if they would like to join the action. Contact details for those interested are in the full release below. DALLAS–(BUSINESS WIRE)–Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Zipcar, Inc. (?Zipcar?) (Nasdaq: ZIP) to Avis Budget Group, Inc. for shareholders. Under the terms of the proposed deal valued at approximately $500 million, Zipcar